Fig. 10: Mineralocorticoid receptor (MR) activation promotes experimental intestinal fibrosis through neutrophil gelatinase-associated lipocalin (NGAL) pathway.

Aldosterone (Aldo), MR ligand promotes fibroblast activation while MR antagonism by spironolactone inhibited it. NGAL is a downstream MR target in intestinal fibrosis. MR antagonism reduced extracellular matrix production in smooth muscle cells (SMC), intestinal fibroblasts, and intestinal endothelial cells. Created in BioRender67.